Patents by Inventor Michael Cuchiara

Michael Cuchiara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250001159
    Abstract: Systems and techniques for improving cardiorenal syndrome (CRS) may be provided. The systems may include a first flow enhancer configured to increase a renal artery pressure. The systems may include a second flow enhancer or flow restrictor configured to reduce a renal vein pressure. Each flow enhancer or flow restrictor may be configured to increase a transrenal pressure gradient, improve filtering and renal perfusion.
    Type: Application
    Filed: June 28, 2024
    Publication date: January 2, 2025
    Applicant: ABIOMED, Inc.
    Inventors: Michael Cuchiara, Soo Young Kim, Sathya Dev Unudurthi, Ralf Westenfeld
  • Publication number: 20250001158
    Abstract: A system and method for cardiorenal syndrome (CRS) therapy are provided. The system may utilize a therapy-delivery device configured to be disposed within a patient. The therapy-delivery device may be, e.g., a blood pump, a blood flow or pressure restrictor or enhancer. The system may include a controller operably coupled to the therapy-delivery device. The controller may be configured to adjust a therapy delivered by the therapy-delivery device based on a parameter related to renal function. The parameter may be measured by a real-time diagnostic sensor. The real-time diagnostic sensor may be integral to the therapy-delivery device, or may be located remotely from the therapy-delivery device, such as on a separate implantable device, or on a wearable medical device.
    Type: Application
    Filed: June 28, 2024
    Publication date: January 2, 2025
    Applicant: ABIOMED, Inc.
    Inventors: Michael Cuchiara, Soo Young Kim, Sathya Dev Unudurthi, Ralf Westenfeld
  • Patent number: 11623093
    Abstract: Neuromodulation is used to enhance left ventricular relaxation and/or left ventricular contractility, during contemporaneous use of a mechanical circulatory support device to increase cardiac output or aid in unloading the heart. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: April 11, 2023
    Assignee: NuXcel Limited
    Inventors: Michael Cuchiara, Stephen C. Masson
  • Patent number: 11185699
    Abstract: A neuromodulation system includes neuromodulation electrodes on an electrode support that is positionable within a blood vessel for transvascular stimulation of target nerves. Cathode surface area, cathode-to-anode spacing, and other parameters are selected for capture of specific types of nerves (sympathetic, parasympathetic, and/or mixed nerves), nerves located at larger or shorter distances from the vascular wall, and also for proper nerve capture for the targeted types of nerves.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: November 30, 2021
    Assignee: NuXcel Limited
    Inventors: Stephen C Masson, Michael Cuchiara, Jean Darnieder
  • Publication number: 20210275816
    Abstract: Neuromodulation is used to enhance left ventricular relaxation and/or left ventricular contractility, during contemporaneous use of a mechanical circulatory support device to increase cardiac output or aid in unloading the heart. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Application
    Filed: May 18, 2021
    Publication date: September 9, 2021
    Applicant: NuXcel Limited
    Inventors: Michael Cuchiara, Stephen C. Masson
  • Patent number: 11033741
    Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: June 15, 2021
    Assignee: NuXcel Limited
    Inventors: Michael Cuchiara, Stephen C Masson
  • Publication number: 20200282217
    Abstract: A catheter system configured for delivering a neuromodulation therapy, includes a first therapeutic element positionable in a first target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch, and a second therapeutic element in a second target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, internal jugular vein, azygos vein or azygos arch. The system and associated method deliver therapeutic energy to at least one parasympathetic nerve fiber external to the first target vessel using the first therapeutic element, and deliver therapeutic energy to at least one sympathetic nerve fiber external to the second target vessel using the second therapeutic element.
    Type: Application
    Filed: April 6, 2020
    Publication date: September 10, 2020
    Inventors: Stephen C. Masson, Michael Cuchiara, Efrain A. Miranda, Richard A. Glenn, A J. Rogers
  • Publication number: 20200269052
    Abstract: A neuromodulation system includes neuromodulation electrodes on an electrode support that is positionable within a blood vessel for transvascular stimulation of target nerves. Cathode surface area, cathode-to-anode spacing, and other parameters are selected for capture of specific types of nerves (sympathetic, parasympathetic, and/or mixed nerves), nerves located at larger or shorter distances from the vascular wall, and also for proper nerve capture for the targeted types of nerves.
    Type: Application
    Filed: October 17, 2017
    Publication date: August 27, 2020
    Inventors: Stephen C. Masson, Michael Cuchiara, Jean Darnieder
  • Publication number: 20200164204
    Abstract: Electrode systems for transvascular stimulation of target nerves include electrode arrays, elements promoting blood flow between electrode surfaces and surrounding vascular walls, electrodes shaped to promote more even current density than electrodes having angular edges, features for retaining the electrode systems with blood vessels, and features for using electrode-carrying elements to asymmetrically distend blood vessel walls towards target nerve structures.
    Type: Application
    Filed: December 2, 2019
    Publication date: May 28, 2020
    Inventors: Stephen C. Masson, Scott Purcell, Michael Cuchiara, Richard A. Glenn
  • Patent number: 10639478
    Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: May 5, 2020
    Assignee: NeuroTronik IP Holding (Jersey) Limited
    Inventors: Michael Cuchiara, Stephen C Masson
  • Patent number: 10525260
    Abstract: Electrode systems for transvascular stimulation of target nerves include electrode arrays, elements promoting blood flow between electrode surfaces and surrounding vascular walls, electrodes shaped to promote more even current density than electrodes having angular edges, features for retaining the electrode systems with blood vessels, and features for using electrode-carrying elements to asymmetrically distend blood vessel walls towards target nerve structures.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: January 7, 2020
    Assignee: NeuroTronik IP Holding (Jersey) Limited
    Inventors: Stephen C Masson, Scott Purcell, Michael Cuchiara, Richard A. Glenn
  • Publication number: 20180214697
    Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Application
    Filed: January 31, 2018
    Publication date: August 2, 2018
    Applicant: NeuroTronik IP Holding (Jersey) Limited
    Inventors: Michael Cuchiara, Stephen C Masson
  • Publication number: 20180214696
    Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Application
    Filed: January 31, 2018
    Publication date: August 2, 2018
    Applicant: NeuroTronik IP Holding (Jersey) Limited
    Inventors: Michael Cuchiara, Stephen C. Masson
  • Publication number: 20180214698
    Abstract: Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
    Type: Application
    Filed: January 31, 2018
    Publication date: August 2, 2018
    Applicant: NeuroTronik IP Holding (Jersey) Limited
    Inventors: Michael Cuchiara, Stephen C. Masson
  • Publication number: 20180126151
    Abstract: Electrode systems for transvascular stimulation of target nerves include electrode arrays, elements promoting blood flow between electrode surfaces and surrounding vascular walls, electrodes shaped to promote more even current density than electrodes having angular edges, features for retaining the electrode systems with blood vessels, and features for using electrode-carrying elements to asymmetrically distend blood vessel walls towards target nerve structures.
    Type: Application
    Filed: August 6, 2015
    Publication date: May 10, 2018
    Inventors: Stephen C Masson, Scott Purcell, Michael Cuchiara, Richard A. Glenn
  • Publication number: 20170312525
    Abstract: A catheter system configured for delivering a neuromodulation therapy, includes a first therapeutic element positionable in a first target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch, and a second therapeutic element in a second target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, internal jugular vein, azygos vein or azygos arch. The system and associated method deliver therapeutic energy to at least one parasympathetic nerve fiber external to the first target vessel using the first therapeutic element, and deliver therapeutic energy to at least one sympathetic nerve fiber external to the second target vessel using the second therapeutic element.
    Type: Application
    Filed: July 16, 2015
    Publication date: November 2, 2017
    Inventors: Stephen C. Masson, Michael Cuchiara, Efrain A. Miranda, Richard A. Glenn, A J. Rogers
  • Publication number: 20170189642
    Abstract: A catheter system configured for delivering a neuromodulation therapy, includes a first therapeutic element positionable in a first target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch, and a second therapeutic element in a second target vessel selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, right brachiocephalic vein, azygos vein or azygos arch. The system and associated method deliver therapeutic energy to at least one parasympathetic nerve fiber external to the first target vessel using the first therapeutic element, and deliver therapeutic energy to at least one sympathetic nerve fiber external to the second target vessel using the second therapeutic element.
    Type: Application
    Filed: March 9, 2015
    Publication date: July 6, 2017
    Inventors: Stephen C. Masson, Michael Cuchiara, Efrain A. Miranda, Richard A. Glenn, A J. Rogers